Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
| Fund/benchmark | Change | |
|---|---|---|
| Price | International Biotechnology Trust (Ordinary Share) | +29.88% |
| NAV | International Biotechnology Trust (Ordinary Share) | +33.12% |
| Morningstar's Benchmark | Nasdaq Biotechnology Index | -- |
Key statistics
As of last trade International Biotechnology Trust (IBT:LSE) traded at 911.43, -8.90% below its 52-week high of 1,000.50, set on Dec 15, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Shares outstanding | 31.90m |
|---|---|
| Market cap | 283.94m GBP |
| Total assets | 340.76m GBP |
| Total expense ratio | -- |
| High | 916.00 |
| Low | 898.00 |
| Previous close | 908.00 |
| Average volume | 77.57k |
|---|---|
| YTD Change | -5.45% |
| Beta | 0.4478 |
| Diluted NAV (est) | 983.90 |
| Diluted NAV (last pub) | 935.39 |
| Premium/Discount | -9.14% |
| Net Gearing | +9.10% |
| Annual div (ADY) | 31.81 GBX |
|---|---|
| Annual div yield (ADY) | 3.57% |
| Div ex-date | Dec 29 2025 |
| Div pay-date | Jan 23 2026 |
Data delayed at least 20 minutes, as of Feb 19 2026 11:31 GMT.
More ▼
